ULK1 and chronic myelogenous leukemia, BCR-ABL1 positive: TRAF6 catalyzed K63-linked polyubiquitination of ULK1 can stabilize ULK1 to promote activation of autophagy, which is related to drug resistance in chronic myeloid leukemia patients [225].